Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Net Shares Issued and Repurchased (2019 - 2026)

Dyadic International's (DYAI) quarterly Net Shares Issued and Repurchased came in at $516250.0 in Q1 2026, down 23.35% year-over-year from $673500.0 in Q1 2025, and down 42.12% quarter-over-quarter from $891875.0 in Q4 2025.

Analysis

Dyadic International (DYAI) Net Shares Issued and Repurchased (2019 - 2026) Analysis & Trends

Dyadic International has disclosed Net Shares Issued and Repurchased across 8 years of filings, most recently posting $516250.0 for Q1 2026.

  • In Q1 2026, Net Shares Issued and Repurchased fell 23.35% year-over-year to $516250.0; the TTM figure through Mar 2026 stood at $516250.0 (down 23.35% YoY), while the FY2025 annual figure was $891875.0, up 7.36% from the prior year.
  • Net Shares Issued and Repurchased came in at $516250.0 for Q1 2026 at Dyadic International, down from $891875.0 in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $891875.0 in Q4 2025 to a low of $75000.0 in Q1 2022.
  • Average Net Shares Issued and Repurchased over 5 years is $682108.3, with a median of $772600.0 recorded in 2024.
  • Year-over-year, Net Shares Issued and Repurchased plunged 89.94% in 2022 and surged 843.8% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $865825.0 in 2022, then declined by 6.98% to $805350.0 in 2023, then advanced by 3.15% to $830725.0 in 2024, then gained by 7.36% to $891875.0 in 2025, then plunged by 42.12% to $516250.0 in 2026.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $516250.0 in Q1 2026, $891875.0 in Q4 2025, and $673500.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Dyadic International 17.78 Mn 9.82 Mn - 516,250.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 516,250.00
Dec 31, 2025 891,875.00
Mar 31, 2025 673,500.00
Dec 31, 2024 830,725.00
Mar 31, 2024 772,600.00
Dec 31, 2023 805,350.00
Mar 31, 2023 707,850.00
Dec 31, 2022 865,825.00
Mar 31, 2022 75,000.00
Dec 31, 2021 870,825.00
Mar 31, 2021 745,825.00
Dec 31, 2020 913,000.00
Dec 31, 2019 1.09 Mn